These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1205 related articles for article (PubMed ID: 26264835)

  • 1. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
    Pardi N; Tuyishime S; Muramatsu H; Kariko K; Mui BL; Tam YK; Madden TD; Hope MJ; Weissman D
    J Control Release; 2015 Nov; 217():345-51. PubMed ID: 26264835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice.
    Andries O; Mc Cafferty S; De Smedt SC; Weiss R; Sanders NN; Kitada T
    J Control Release; 2015 Nov; 217():337-44. PubMed ID: 26342664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal delivery of frataxin mRNA encapsulated in lipid nanoparticles to dorsal root ganglia as a potential therapeutic for Friedreich's ataxia.
    Nabhan JF; Wood KM; Rao VP; Morin J; Bhamidipaty S; LaBranche TP; Gooch RL; Bozal F; Bulawa CE; Guild BC
    Sci Rep; 2016 Feb; 6():20019. PubMed ID: 26883577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid Nanoparticle Packaging Is an Effective and Nontoxic mRNA Delivery Platform in Embryonic Zebrafish.
    Patton C; Farr GH; An D; Martini PGV; Maves L
    Zebrafish; 2018 Jun; 15(3):217-227. PubMed ID: 29369745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format.
    Phua KK; Leong KW; Nair SK
    J Control Release; 2013 Mar; 166(3):227-33. PubMed ID: 23306021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA.
    Blakney AK; McKay PF; Yus BI; Aldon Y; Shattock RJ
    Gene Ther; 2019 Sep; 26(9):363-372. PubMed ID: 31300730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles.
    Evers MJW; Du W; Yang Q; Kooijmans SAA; Vink A; van Steenbergen M; Vader P; de Jager SCA; Fuchs SA; Mastrobattista E; Sluijter JPG; Lei Z; Schiffelers R
    J Control Release; 2022 Mar; 343():207-216. PubMed ID: 35077739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Throughput
    Hamilton AG; Swingle KL; Thatte AS; Mukalel AJ; Safford HC; Billingsley MM; El-Mayta RD; Han X; Nachod BE; Joseph RA; Metzloff AE; Mitchell MJ
    ACS Nano; 2024 Jun; 18(25):16151-16165. PubMed ID: 38861479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.
    Qiu M; Tang Y; Chen J; Muriph R; Ye Z; Huang C; Evans J; Henske EP; Xu Q
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35173043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside Modified mRNA Vaccines for Infectious Diseases.
    Pardi N; Weissman D
    Methods Mol Biol; 2017; 1499():109-121. PubMed ID: 27987145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.
    Kauffman KJ; Mir FF; Jhunjhunwala S; Kaczmarek JC; Hurtado JE; Yang JH; Webber MJ; Kowalski PS; Heartlein MW; DeRosa F; Anderson DG
    Biomaterials; 2016 Dec; 109():78-87. PubMed ID: 27680591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Nanoparticle Formulations for Enhanced Co-delivery of siRNA and mRNA.
    Ball RL; Hajj KA; Vizelman J; Bajaj P; Whitehead KA
    Nano Lett; 2018 Jun; 18(6):3814-3822. PubMed ID: 29694050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size.
    Di J; Du Z; Wu K; Jin S; Wang X; Li T; Xu Y
    Pharm Res; 2022 Jan; 39(1):105-114. PubMed ID: 35080707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles.
    Yanez Arteta M; Kjellman T; Bartesaghi S; Wallin S; Wu X; Kvist AJ; Dabkowska A; Székely N; Radulescu A; Bergenholtz J; Lindfors L
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3351-E3360. PubMed ID: 29588418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
    Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
    ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
    Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
    J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.
    Tombácz I; Laczkó D; Shahnawaz H; Muramatsu H; Natesan A; Yadegari A; Papp TE; Alameh MG; Shuvaev V; Mui BL; Tam YK; Muzykantov V; Pardi N; Weissman D; Parhiz H
    Mol Ther; 2021 Nov; 29(11):3293-3304. PubMed ID: 34091054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Cholesterol Content of Lipid Composition in mRNA-LNPs on the Protein Expression in the Injected Site and Liver After Local Administration in Mice.
    Kawaguchi M; Noda M; Ono A; Kamiya M; Matsumoto M; Tsurumaru M; Mizukami S; Mukai H; Kawakami S
    J Pharm Sci; 2023 May; 112(5):1401-1410. PubMed ID: 36596392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular RNA delivery by lipid nanoparticles: Diffusion, degradation, and release.
    Zhdanov VP
    Biosystems; 2019 Nov; 185():104032. PubMed ID: 31563119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.